Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

1,600

Participants

Timeline

Start Date

December 12, 2011

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions
Operable Breast Cancer
Interventions
DRUG

0.5% lignocaine 60mM

Trial Locations (11)

110029

All India Institute of Medical Science, New Delhi

110092

Max Super Speciality Hospital, Delhi

400012

Tata Memorial Centre Mumbai, Mumbai

411044

Sterling Multi Speciality Hospital, Pune

416008

Kolhapur Cancer Centre PVT LTD, Kolhāpur

416410

Shree Siddhivinayak Ganapti Cancer Hospital Sangli, Sangli

500034

Basavatarakam Indo- American Cancer Hospital, Hyderabad

670103

Malabar Cancer Centre, Kannur

781016

Dr. B Barooha Cancer Institute, Guwahati

793012

North Eastern Indira Gandhi Regional Institute of Health & Medical Sciences (NEIGRIHMS), Shillong

380 016

Gujarat Cancer & Research Institute (GCRI), Ahmedabad

All Listed Sponsors
collaborator

Shri Siddhivinayak Ganpati Cancer Hospital

UNKNOWN

collaborator

Kolhapur Cancer Centre (KCC)

UNKNOWN

collaborator

Max Super Speciality Hospital

OTHER

collaborator

Basavatarakam Indo American Cancer Hospital & Research Institute

OTHER

collaborator

Malabar Cancer Centre (MCC)

UNKNOWN

collaborator

North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS)

UNKNOWN

collaborator

All India Institute of Medical Sciences

OTHER

collaborator

Gujarat Cancer & Research Institute

OTHER

collaborator

Sterling Multi Speciality Hospital (SMSH)

UNKNOWN

collaborator

Dr. B Barooha Cancer Institute (BBCI)

UNKNOWN

lead

Tata Memorial Hospital

OTHER_GOV